CVS Health Corp. on Wednesday lifted its full-year adjusted earnings forecast after robust demand for COVID-19 vaccinations and tests helped the U.S. healthcare conglomerate beat analysts’ estimates for third-quarter profit.
Rival Walgreens Boots Alliance also signaled a boost from higher demand for vaccinations following the spread of the Delta variant.
